Table 1

Detailed description of clinical symptoms and data derived from blood tests in COVID-19+ athletes

NIgG index (normal <1.4)Previous COVID-19-related symptomsPost
WCC (×109/L) (normal 4–10)
Post
Lymphocytes (×109/L) (normal 1.1–4)
Post
PLT (×109/L) (normal 150–400)
Post
AST (U/L) (normal <34)
Post
ALT (U/L) (normal <49)
Post
TnI (pg/mL) (normal <57)
Post
CRP (mg/dL) (normal <0.5)
Post
Ferritin (ng/mL) (normal 22–330)
Post
IL-6 (pg/mL) (normal <5.9)
Post
D-dimer (FEU ng/mL) (normal <500)
Post
Coagulation (PT, aPTT, INR)
Post
Creatinine (mg/dL) (normal 0.67–1.17)
14.65None8.47 (pre: 7.68)2.15 (pre: 2.23)302 (pre: 279)21 (pre: 33)29 (pre: 35)116.61*<0.40 (pre: <0.40)86 (pre: 91)<2196Normal1.04 (pre: 1.06)
21.75Ageusia8.43 (pre: 8.06)1.99 (pre: 2.96)268 (pre: 268)66* (pre: 49*)45 (pre: 35)7.7<0.40 (pre: <0.40)39 (pre: 82)2.1229Normal1.18* (pre: 0.93)
32.36None3.95 (pre: n.a.)2.52 (pre: n.a.)245 (pre: n.a.)72* (pre: n.a.)48 (pre: n.a.)13<0.40 (pre: n.a.)29 (pre: n.a.)3.1289Normal1.03 (pre: n.a.)
41.65None4.32 (pre: 5.02)1.78 (pre: 2.24)292 (pre: 282)20 (pre: 20)15 (pre: 16)2.67<0.40 (pre: <0.40)51 (pre: 25)3.4<190Normal0.98 (pre: 0.95)
52.46Ageusia, anosmia5.48 (pre: 4.65)1.81 (pre: 1.53)202 (pre: 215)25 (pre: 21)18 (pre: 12)3.33<0.40 (pre: <0.40)41 (pre: 33)3.5<190Normal0.94 (pre: 0.92)
64.42Fever >37.5°C, arthromyalgia5.08 (pre: 6.22)1.7 (pre: 2.17)212 (pre: 219)39* (pre: 32)34 (pre: 32)<2.50<0.40 (pre: <0.40)39 (pre: 56)<2<190Normal1.19* (pre: 1.14)
74.11Ageusia, sore throat4.8 (pre: 7.05)2.29 (pre: 3.36)206 (pre: 247)22 (pre: 31)20 (pre: 25)3.41<0.40 (pre: <0.40)50 (pre: 49)4.4<190Normal1.14 (pre: 1.1)
82.46None7.6 (pre: 7.21)2.08 (pre: 2.57)228 (pre: 194)22 (pre: 30)21 (pre: 31)3.44<0.40 (pre: <0.40)85 (pre: 87)3.6<190Normal1.18* (pre: 1.23*)
92.96Fever >37.5°C, asthenia4.59 (pre: n.a.)1.56 (pre: n.a.)272 (pre: n.a.)44* (pre: n.a.)37 (pre: n.a.)4.47<0.40 (pre: n.a.)47 (pre: n.a.)2.3<190Normal1.01 (pre: n.a.)
102.19Asthenia, headache4.72 (pre: 7.74)2.07 (pre: 2.95)200 (pre: 219)20 (pre: 20)19 (pre: 16)3.17<0.40 (pre: <0.40)33 (pre: 42)<2465Normal1.06 (pre: 1.01)
112.85None4.95 (pre: 6.14)1.76 (pre: 2.49)193 (pre: 194)20 (pre: 42*)23 (pre: 28)26.83<0.40 (pre: <0.40)257 (pre: 233)<2<190Normal1.03 (pre: 1.03)
127.35Fever >37.5°C, cough, asthenia, ageusia, arthromyalgia5.7 (pre: 5.03)1.52 (pre: 1.59)204 (pre: 201)36* (pre: 52*)21 (pre: 40)<2.50<0.40 (pre: <0.40)140 (pre: 208)14.3*<190Normal0.95 (pre: 1.1)
135.11Fever >37.5°C, anosmia, ageusia, nocturnal dyspnoea4.17 (pre: 4.12)2 (pre: 2.14)244 (pre: 227)48* (pre: 36*)44 (pre: 23)<2.50<0.40 (pre: <0.40)26 (pre: 39)3.4<190Normal1 (pre: 0.99)
141.64Fever >37.5°C5.59 (pre: 12.02*)2.73 (pre: 1.94)214 (pre: 198)20 (pre: 63*)11 (pre: 31)2.98<0.40 (pre: <0.40)47 (pre: 39)2.1<190Normal1.12 (pre: 1.09)
155.24None5.01 (pre: 5.54)2.09 (pre: 2.14)172 (pre: 197)38* (pre: 57*)32 (pre: 38)8.17<0.40 (pre: <0.40)11* (pre: 16*)3<190Normal1.16 (pre: 1.14)
164.73Asthenia8.34 (pre: 11.61*)1.83 (pre: 1.59)238 (pre: 188)21 (pre: 31)21 (pre: 20)2.73<0.40 (pre: <0.40)89 (pre: 79)3.8247Normal1.13 (pre: 0.95)
175.8Fever >37.5°C5.85 (pre: 5.47)3.3 (pre: 1.98)295 (pre: 340)29 (pre: 29)22 (pre: 20)3.19<0.40 (pre: <0.40)90 (pre: 77)2.9<190Normal1.22* (pre: 1.25*)
182.43Fever >37.5°C, cough, asthenia, anosmia3.67 (pre: 5.88)1.47 (pre: 2.17)255 (pre: 262)20 (pre: 30)13 (pre: 19)22.01<0.40 (pre: <0.40)179 (pre: 99)8.7*<190Normal0.98 (pre: 1)
  • Post: post-COVID-19 value; pre: pre-COVID-19 value.

  • *Abnormal value.

  • ALT, alanine transaminase; aPTT, activated partial thromboplastin time; AST, aspartate transaminase; CRP, C reactive protein; FEU, fibrinogen equivalent units; IL-6, interleukin 6; INR, international normalised ratio; N.A., not available; PLT, platelet count; PT, prothrombin time; TnI, high-sensitivity troponin I; WCC, white cell count.